Evidence map›Paper›PMID 41200866›Full record

ArticleAnnals of neurology2026

Association between Human Leukocyte Antigen Alleles and Neuropathological Outcomes in Lewy Body Disease.

Marios Gavrielatos, Michael G Heckman, Alexandra I Soto-Beasley, Sophia G Blumenfeld, Xu Hou, Shunsuke Koga, Melissa E Murray, Koji Kasanuki, Daisuke Ono, Fabienne C Fiesel and 25 more

Abstract read
In one paragraph

Article in Annals of neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors.

Marios GavrielatosDepartment of Neuroscience, Mayo Clinic, Jacksonville, Florida, USA.ORCID 0000-0002-6052-5517
Michael G HeckmanDivision of Clinical Trials and Biostatistics, Mayo Clinic, Jacksonville, Florida, USA.ORCID 0000-0003-3770-9331
Alexandra I Soto-BeasleyDepartment of Neuroscience, Mayo Clinic, Jacksonville, Florida, USA.
Sophia G BlumenfeldDivision of Clinical Trials and Biostatistics, Mayo Clinic, Jacksonville, Florida, USA.
Xu HouDepartment of Neuroscience, Mayo Clinic, Jacksonville, Florida, USA.
Shunsuke KogaDepartment of Neuroscience, Mayo Clinic, Jacksonville, Florida, USA.ORCID 0000-0001-8868-9700
Melissa E MurrayDepartment of Neuroscience, Mayo Clinic, Jacksonville, Florida, USA.
Koji KasanukiDepartment of Neuroscience, Mayo Clinic, Jacksonville, Florida, USA.
Daisuke OnoDepartment of Neuroscience, Mayo Clinic, Jacksonville, Florida, USA.
Fabienne C FieselDepartment of Neuroscience, Mayo Clinic, Jacksonville, Florida, USA.ORCID 0000-0002-1919-9676
Ryan J UittiDepartment of Neurology, Mayo Clinic, Jacksonville, Florida, USA.
Julie A FieldsDepartment of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota, USA.
Hugo BothaDepartment of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
Vijay K RamananDepartment of Neurology, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0001-6591-8734
Kejal KantarciDepartment of Neuroradiology, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0002-8001-2081
Val J LoweDepartment of Nuclear Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Clifford R JackDepartment of Neuroradiology, Mayo Clinic, Rochester, Minnesota, USA.
Nilufer Ertekin-TanerDepartment of Neuroscience, Mayo Clinic, Jacksonville, Florida, USA.
J Raphael GibbsComputational Biology Group, Laboratory of Neurogenetics, National Institute on Aging, Bethesda, Maryland, USA.
Bryan J TraynorNeuromuscular Diseases Research Section, Laboratory of Neurogenetics, National Institute on Aging, Bethesda, Maryland, USA.
Clifton L DalgardDepartment of Anatomy, Physiology and Genetics, Uniformed Services University of the Health Science, Bethesda, Maryland, USA.
Rodolfo SavicaDepartment of Neurology, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0002-2543-0627
Jonathan Graff-RadfordDepartment of Neurology, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0003-2770-0691
Ronald C PetersenDepartment of Neurology, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0002-8178-6601
R Ross ReichardDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
Neill R Graff-RadfordDepartment of Neurology, Mayo Clinic, Jacksonville, Florida, USA.
Tanis J FermanDepartment of Psychiatry and Psychology, Mayo Clinic, Jacksonville, Florida, USA.
Bradley F BoeveDepartment of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
Zbigniew K WszolekDepartment of Neurology, Mayo Clinic, Jacksonville, Florida, USA.
Wolfdieter SpringerDepartment of Neuroscience, Mayo Clinic, Jacksonville, Florida, USA.
Ziv Gan-OrThe Neuro (Montreal Neurological Institute-Hospital), Montreal, Quebec, Canada.ORCID 0000-0003-0332-234X
Emmanuel MignotCenter for Sleep Sciences and Medicine, Stanford University, Palo Alto, California, USA.
Sonja W ScholzNeurodegenerative Diseases Research Section, National Institute of Neurological Disorders and Stroke, Bethesda, Maryland, USA.ORCID 0000-0002-6623-0429
Dennis W DicksonDepartment of Neuroscience, Mayo Clinic, Jacksonville, Florida, USA.ORCID 0000-0001-7189-7917
Owen A RossDepartment of Neuroscience, Mayo Clinic, Jacksonville, Florida, USA.ORCID 0000-0003-4813-756X

Funding

Technology and Remote Assessment CoreU19AG063911 · NIA · MAYO CLINIC ROCHESTER · PI WILLIAM W SEELEY · 2019 to 2026
$120.9M
Project: Predicting PhenoconversionU19AG071754 · NIA · WASHINGTON UNIVERSITY · PI Bradley F Boeve, Yo-El S Ju · 2021 to 2026
$41.2M
THE PGRN/TDP-43 AXIS IN ALZHEIMER?S DISEASE AND NEURODEGENERATIONP50AG016574 · NIA · MAYO CLINIC ROCHESTER · PI PETERSEN, RONALD C · 1999 to 2018
$36.9M
Research Education ComponentP30AG062677 · NIA · MAYO CLINIC ROCHESTER · PI KEJAL KANTARCI · 2019 to 2026
$33.5M
Longitudinal Imaging Biomarkers of Prodromal DLBU01NS100620 · NINDS · MAYO CLINIC ROCHESTER · PI Bradley F Boeve, KEJAL KANTARCI · 2017 to 2026
$19.2M
Genetic characterization of atypical parkinsonismZIANS003154 · NINDS · NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE · PI SCHOLZ, SONJA · 2016 to 2025
$15.4M
Utilization of proteomics and lipidomics to identify modifiers of LBDU54NS110435 · NINDS · MAYO CLINIC JACKSONVILLE · PI MCLEAN, PAMELA J · 2019 to 2023
$14.5M
Neuropathology CoreP50NS072187 · NINDS · MAYO CLINIC JACKSONVILLE · PI DICKSON, DENNIS WILLIAM · 2010 to 2017
$8.7M
Investigating Resistance and Resilience Mechanisms in Alzheimer’s DiseaseR01AG056366 · NIA · MAYO CLINIC ROCHESTER · PI PRASHANTHI VEMURI · 2017 to 2026
$7.0M
Bio-RaPID: Biomarkers and Rates of Progression In Dementia.R01AG089380 · NIA · MAYO CLINIC JACKSONVILLE · PI DAY, GREGORY SCOTT · 2024 to 2025
$4.1M
Elucidating the Pathomechanisms of APOE4 in Lewy Body DementiaR01AG087165 · NIA · MAYO CLINIC JACKSONVILLE · PI Owen A Ross, Na Zhao · 2024 to 2026
$2.3M
Genome sequencing of Lewy Body Dementia and Frontotemporal Dementia: a public resource for the study of Alzheimers disease and related dementiasZIAAG000935 · NIA · NATIONAL INSTITUTE ON AGING · PI TRAYNOR, BRYAN · 2017 to 2025
$771k
American Parkinson Disease Association (APDA) Center for Advanced ResearchAmerican Parkinson Disease Association (APDA) Mayo Clinic Information and Referral CenterHaworth Family Professorship in Neurodegenerative Diseases fundIntramural NIH HHS ZIA AG000935Intramural NIH HHS ZIA NS003154Intramural Research Program of the U.S. National Institutes of Health 1ZIAAG000935Intramural Research Program of the U.S. National Institutes of Health 1ZIANS003154Little Family FoundationMayo Clinic Dorothy and Harry T. Mangurian Jr. Lewy body dementia programMayo Clinic Florida Morris K. Udall Parkinson's Disease Research Center of Excellence NINDS P50 #NS072187Mayo Clinic LBD Center WithOut Walls U54-NS110435Mayo Clinic Lewy Body Dementia Association (LBDA) Research Center of ExcellenceMichael J. Fox Foundation for Parkinson's ResearchNIA NIH HHS P30 AG062677NIA NIH HHS P50 AG016574NIA NIH HHS R01 AG056366NIA NIH HHS R01 AG087165NIA NIH HHS R01 AG089380NIA NIH HHS U19 AG063911NIA NIH HHS U19 AG071754NIH/NIA 1U19AG063911NIH/NINDS U19AG063911NINDS NIH HHS P50 NS072187NINDS NIH HHS U01 NS100620NINDS NIH HHS U54 NS110435PPND Family FoundationTed Turner and familyThe Albertson Parkinson's Research Foundation
6 · The paper itself

Abstract

objectiveLewy body disease (LBD) is a complex neurodegenerative disorder characterized by the accumulation of misfolded α-synuclein in the brain. Neuroinflammation has long been implicated in LBD pathogenesis, and recent genetic studies in Parkinson's disease (a clinical manifestation of LBD) have shown consistent association with the human leukocyte antigen (HLA) gene complex. Here, we assessed whether variation in HLA alleles influences neuropathological burden in a neuropathologically-defined series of LBD cases.

methodsWe conducted a comprehensive analysis of HLA allelic variants in a cohort of 539 LBD cases of European descent from the Mayo Clinic brain bank. High-resolution whole-genome sequencing was used, and the HLA alleles of each sample were called using the HLA*LA tool and assessed for association with neuropathological outcomes.

resultsOur analysis identified 1 significant (P < 3.43 × 10

interpretationThis study provides a detailed evaluation of the relationship between HLA alleles and LBD pathology, highlighting the importance of immune-related genetic factors in the etiology of LBD. ANN NEUROL 2026;99:492-501.

Indexed as

HLA AntigensLewy Body DiseaseAgedAged, 80 and overAllelesBrainCohort StudiesFemaleHumansMaleMiddle AgedHLA Antigens

Identifiers

PMID41200866
PMCPMC12814941

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.